Clinical Trial Update: Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating clofarabine with low-dose total-body irradiation as conditioning for donor peripheral blood stem cell transplantation in acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-04-16